Current Neuro-Oncology
Volume
4 Number 9
30 September 2002
Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 9, 30 September
*
Baker MJ, Brem S, Daniels S,
Sherman B, Phuphanich S.
Complete
response of a recurrent, multicentric malignant glioma in a
patient treated with phenylbutyrate.
J
Neurooncol. 2002 Sep;59(3):239-42∟.
doi: 10.1023/a:1019905127442∟.
PMID: 12241121∟.
Case report. ˍ
Kristof RA, Neuloh G, Hans V,
Deckert M, Urbach H, Schlegel U, Simon M, Schramm J.
Combined
surgery, radiation, and PCV chemotherapy for astrocytomas compared
to oligodendrogliomas and oligoastrocytomas WHO grade III.
J
Neurooncol. 2002 Sep;59(3):231-7∟.
doi: 10.1023/a:1019987116596∟.
PMID: 12241120∟.
Observational study. ˍ
Peretti-Viton P, Brunel H, Chinot
O, Daniel C, Barrié M, Bouvier C, Figarella-Branger D,
Fuentes S, Dufour H, Grisoli F.
Histological
and MR correlations in Gliomatosis cerebri.
J
Neurooncol. 2002 Sep;59(3):249-59∟.
doi: 10.1023/a:1019934901750∟.
PMID: 12241123∟.
Observational study. ˍ
Wick W, Hermisson M, Kortmann RD,
Küker WM, Duffner F, Dichgans J, Bamberg M, Weller
M.
Neoadjuvant
gemcitabine/treosulfan chemotherapy for newly diagnosed
glioblastoma: a phase II study.
J
Neurooncol. 2002 Sep;59(2):151-5∟.
doi: 10.1023/a:1019641314661∟.
PMID: 12241108∟.
Interventional study. ˍ
MacKillop LH, O'Donnell J, Ayliffe
W, Jayawardene SA.
Never
forget the risks of
immunosuppression.
Int
J Clin Pract. 2002 Sep;56(7):554-5∟.
doi: 10.1111/j.1742-1241.2002.tb11319.x∟.
PMID: 12296622∟.
Case report˰ ˍ
O'Neill BP, Blondal H, Yang P,
Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel
DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H.
Risk
of cancer among
relatives of patients with glioma.
Cancer
Epidemiol Biomarkers Prev. 2002 Sep
1;11(9):921-4∟.
PMID: 12223439∟.
Observational study. ˍ
Hargrave DR, Bouffet E, Gammon J,
Tariq N, Grant RM, Baruchel S.
Phase
I study of fotemustine in pediatric patients with refractory brain
tumors.
Cancer.
2002 Sep 5;95(6):1294-301∟.
doi: 10.1002/cncr.10814∟.
PMID: 12216098∟.
Interventional study. ˍ
Gutmann DH, Rasmussen SA,
Wolkenstein P, MacCollin MM, Guha A, Inskip PD, North KN, Poyhonen
M, Birch PH, Friedman JM.
Gliomas
presenting after age 10 in individuals with neurofibromatosis type
1 (NF1).
Neurology.
2002 Sep 10;59(5):759-61∟.
doi: 10.1212/wnl.59.5.759∟.
PMID: 12221173∟.
Observational study. ˍ
Bacon CL, Gallagher HC, Haughey JC,
Regan CM.
Antiproliferative
action of valproate is associated with aberrant expression and
nuclear translocation of cyclin D3 during the C6 glioma G1
phase.
J
Neurochem. 2002 Sep 18;83(1):12-9∟.
doi: 10.1046/j.1471-4159.2002.01081.x∟.
PMID: 12358724∟.
Laboratory investigation. ˍ
Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P,
Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki
AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L,
Morton KE, Mavroukakis SA, White DE, Rosenberg SA.
Cancer
regression and autoimmunity in patients after clonal repopulation
with antitumor lymphocytes.
Science.
2002 Sep 19;298(5594):850-4. doi:
10.1126/science.1076514. PMID:
12242449. Trial registration ID: NA. ˍ
*
Scott JN, Brasher PM, Sevick RJ,
Rewcastle NB, Forsyth PA.
How
often are nonenhancing supratentorial gliomas malignant? A
population study.
Neurology.
2002 Sep 24;59(6):947-9∟.
doi: 10.1212/wnl.59.6.947∟.
PMID: 12297589∟.
Observational study. ˍ
Gumprecht H, Ebel GK, Auer DP,
Lumenta CB.
Neuronavigation
and functional MRI for surgery in patients with lesion in eloquent
brain areas.
Minim
Invasive Neurosurg. 2002 Sep 26;45(3):151-3∟.
doi: 10.1055/s-2002-34341∟.
PMID: 12353162∟.
Observational study. ˍ